CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Bristol Myers' partner Biokin says bispecific ADC clears fourth cancer trial in China

Related Companies

Read the original article

Published by Endpoints News on August 19, 2026 11:05 AM

Read Original